Adding the clinical framing, because it changes how the question reads.
Compounded has been just as effective for me. If compounded supply is the concern, the COA from my 503B pharmacy shows 99.1% purity. Verified by Janoshik.
NicoleRaleigh said:Compounding pharmacy response time test for compounded supply: I email customer service at odd hours to test responsiveness.
503A vs 503B compounding pharmacies for compounded supply — this distinction matters enormously:
| Feature | 503A | 503B |
|---|---|---|
| Regulation | State Board of Pharmacy | FDA-registered |
| Prescription | Required (patient-specific) | Can compound without patient Rx |
| Testing | Varies by state | cGMP required |
| Scale | Small batches | Larger production |
| Quality consistency | Variable | Generally higher |
I strongly recommend 503B facilities. The FDA oversight and cGMP requirements mean more consistent product quality.
NicoleRaleigh said:Compounding pharmacy response time test for compounded supply: I email customer service at odd hours to test responsiveness.
Price comparison for compounded supply across sources I've used:
| Source | Monthly Cost | Type | Purity Verified |
|---|---|---|---|
| Brand (Ozempic) | $979 | FDA-approved | N/A (pharma) |
| 503B Compounding | $159 | cGMP compounded | Yes (in-house) |
| 503A Compounding | $129 | Patient-specific | Varies |
| Research peptide | $44 | Not for human use | Often Janoshik |
I use the 503B option — best balance of quality, cost, and legality. The brand price is insane but insurance can help if you qualify.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsFollowing on from NicoleRaleigh — and this may be the naive question:
What did you change at the same time, and can you separate the two now?
Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Report rather than reply if it drifts again.